Education

Ph.D. in molecular biology (Immunology), Osaka University, Japan

Current position

Assistant Professor, Immune Regulation, Immunology Frontier Research Center (IFReC), Osaka University, Japan

Publications

1. Tanaka, T., Narazaki, M. and Kishimoto, T. (2016). Immunotherapeutic implications of IL-6 blockade for cytokine storm. Immunotherapy 8(8): 959-970.

2. Masuda, K. and Kishimoto, T. (2016). CD5: A New Partner for IL-6. Immunity 44(4): 720-722.

3. Masuda, K., Ripley, B., Nyati, K. K., Dubey, P. K., Zaman, M. M., Hanieh, H., Higa, M., Yamashita, K., Standley, D. M., Mashima, T., Katahira, M., Okamoto, T., Matsuura, Y., Takeuchi, O. and Kishimoto, T. (2016). Arid5a regulates naive CD4+ T cell fate through selective stabilization of Stat3 mRNA. J Exp Med 213(4): 605-619.

4. Millrine, D., Miyata, H., Tei, M., Dubey, P., Nyati, K., Nakahama, T., Gemechu, Y., Ripley, B. and Kishimoto, T. (2016). Immunomodulatory drugs inhibit TLR4-induced type-1 interferon production independently of Cereblon via suppression of the TRIF/IRF3 pathway. Int Immunol 28(6): 307-315.

5. Chinen, I., Nakahama, T., Kimura, A., Nguyen, N. T., Takemori, H., Kumagai, A., Kayama, H., Takeda, K., Lee, S., Hanieh, H., Ripley, B., Millrine, D., Dubey, P. K., Nyati, K. K., Fujii-Kuriyama, Y., Chowdhury, K. and Kishimoto, T. (2015). The aryl hydrocarbon receptor/microRNA-212/132 axis in T cells regulates IL-10 production to maintain intestinal homeostasis. Int Immunol 27(8): 405-415.

6. Kishimoto, T. (2015). Introduction: Antibody-targeted therapy special issue. Int Immunol 27(1): 1-2.

7. Nguyen, N. T., Nakahama, T., Nguyen, C. H., Tran, T. T., Le, V. S., Chu, H. H. and Kishimoto, T. (2015). Aryl hydrocarbon receptor antagonism and its role in rheumatoid arthritis. J Exp Pharmacol 7: 29-35.